{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:13:52Z","timestamp":1793049232727,"version":"4.5.0"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurodegenerative diseases, specifically Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s disease (HD), and Amyotrophic Lateral Sclerosis (ALS) are defined by progressively increased neuronal loss that lacks curative therapies. Increasing evidence supports that non-canonical regulated cell death pathways including ferroptosis, necroptosis, pyroptosis, and parthanatos, are implicated in pathological mechanisms of neuroinflammation, and oxidative stress, and mitochondrial dysfunction, likely impacting neurodegenerative pathologies. In this review, we summarize the existing literature on the molecular pathways and potential pathogenic implications of these cell death pathways in neurodegenerative diseases, highlighting their upstream triggers, regulatory proteins, and downstream effectors. We also briefly describe representative pharmacological agents, including ferrostatin-1, necrostatin-1, MCC950 and PARP-inhibitors, that have shown neuroprotective effects in experimental studies. Experimental studies provide valuable information, but translation to clinical treatments presents barriers including overlapping regulated cell death mechanisms, constraints of bloodbrain barrier penetrance and concern for safety. Future development may come through concepts such as biomarker-based patient stratification strategies, multivalent interventions, and improved translational models. Identifying these new regulated cell death pathways may eventually provide new avenues to slow the progression of neurodegeneration and develop more targeted therapies.<\/jats:p>","DOI":"10.1007\/s10495-026-02260-y","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:34:35Z","timestamp":1771274075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic frontiers"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-4963","authenticated-orcid":false,"given":"Nilufer","family":"Ercin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-915X","authenticated-orcid":false,"given":"Nail","family":"Besli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-7314","authenticated-orcid":false,"given":"Merve","family":"Beker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-8560","authenticated-orcid":false,"given":"Ulkan","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2260_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-025-02145-7","volume":"10","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Liu J, Huang S et al (2025) Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances. Signal Transduct Target Ther 10:76. https:\/\/doi.org\/10.1038\/s41392-025-02145-7","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/bph.16078","volume":"180","author":"AG de la Fuente","year":"2023","unstructured":"de la Fuente AG, Pelucchi S, Mertens J et al (2023) Novel therapeutic approaches to target neurodegeneration. Br J Pharmacol 180:1651\u20131673. https:\/\/doi.org\/10.1111\/bph.16078","journal-title":"Br J Pharmacol"},{"key":"2260_CR3","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357","journal-title":"Ageing Res Rev"},{"key":"2260_CR4","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cells13221838","volume":"13","author":"M Mustafa","year":"2024","unstructured":"Mustafa M, Ahmad R, Tantry IQ et al (2024) Apoptosis: A comprehensive overview of signaling Pathways, morphological Changes, and physiological significance and therapeutic implications. Cells 13:1838. https:\/\/doi.org\/10.3390\/cells13221838","journal-title":"Cells"},{"key":"2260_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E et al (2023) Apoptotic cell death in disease\u2014Current Understanding of the NCCD 2023. Cell Death Differ 30:1097\u20131154. https:\/\/doi.org\/10.1038\/s41418-023-01153-w","journal-title":"Cell Death Differ"},{"key":"2260_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41420-024-01957-w","volume":"10","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xiang Y, Liu S et al (2024) RIPK3 signaling and its role in regulated cell death and diseases. Cell Death Discov 10:200. https:\/\/doi.org\/10.1038\/s41420-024-01957-w","journal-title":"Cell Death Discov"},{"key":"2260_CR7","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim B-S et al (2023) Diversity and complexity of cell death: a historical review. Exp Mol Med 55:1573\u20131594. https:\/\/doi.org\/10.1038\/s12276-023-01078-x","journal-title":"Exp Mol Med"},{"key":"2260_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y et al (2022) Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 7:196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F (2020) The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol 20:143\u2013157. https:\/\/doi.org\/10.1038\/s41577-019-0228-2","journal-title":"Nat Rev Immunol"},{"key":"2260_CR10","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1097\/CM9.0000000000003363","volume":"137","author":"L Gao","year":"2024","unstructured":"Gao L, Manaenko A, Zeng F et al (2024) Efferocytosis: A new therapeutic target for stroke. Chin Med J (Engl) 137:2843\u20132850. https:\/\/doi.org\/10.1097\/CM9.0000000000003363","journal-title":"Chin Med J (Engl)"},{"key":"2260_CR11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41417-024-00765-9","volume":"31","author":"J Gao","year":"2024","unstructured":"Gao J, Xiong A, Liu J et al (2024) PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther 31:970\u2013983. https:\/\/doi.org\/10.1038\/s41417-024-00765-9","journal-title":"Cancer Gene Ther"},{"key":"2260_CR12","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1002\/mco2.588","volume":"5","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhu H, Zhao J et al (2024) Multi-omics analysis reveals a crosstalk between ferroptosis and peroxisomes on steatotic graft failure after liver transplantation. MedComm 5:e588. https:\/\/doi.org\/10.1002\/mco2.588","journal-title":"MedComm"},{"key":"2260_CR13","doi-asserted-by":"publisher","unstructured":"Goel P, Chakrabarti S, Goel K et al (2022) Neuronal cell death mechanisms in alzheimer\u2019s disease: an insight. Front Mol Neurosci 15. https:\/\/doi.org\/10.3389\/fnmol.2022.937133","DOI":"10.3389\/fnmol.2022.937133"},{"key":"2260_CR14","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.3390\/ijms241210127","volume":"24","author":"L Tang","year":"2023","unstructured":"Tang L, Liu S, Li S et al (2023) Induction mechanism of Ferroptosis, Necroptosis, and pyroptosis: A novel therapeutic target in nervous system diseases. Int J Mol Sci 24:10127. https:\/\/doi.org\/10.3390\/ijms241210127","journal-title":"Int J Mol Sci"},{"key":"2260_CR15","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.4103\/NRR.NRR-D-24-00025","volume":"20","author":"R Song","year":"2025","unstructured":"Song R, Yin S, Wu J, Yan J (2025) Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials. Neural Regen Res 20:2245\u20132263. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00025","journal-title":"Neural Regen Res"},{"key":"2260_CR16","doi-asserted-by":"publisher","first-page":"1005182","DOI":"10.3389\/fncel.2022.1005182","volume":"16","author":"Y Ji","year":"2022","unstructured":"Ji Y, Zheng K, Li S et al (2022) Insight into the potential role of ferroptosis in neurodegenerative diseases. Front Cell Neurosci 16:1005182. https:\/\/doi.org\/10.3389\/fncel.2022.1005182","journal-title":"Front Cell Neurosci"},{"key":"2260_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbi.2024.02.001","volume":"117","author":"A Oladapo","year":"2024","unstructured":"Oladapo A, Jackson T, Menolascino J, Periyasamy P (2024) Role of pyroptosis in the pathogenesis of various neurological diseases. Brain Behav Immun 117:428\u2013446. https:\/\/doi.org\/10.1016\/j.bbi.2024.02.001","journal-title":"Brain Behav Immun"},{"key":"2260_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mco2.108","volume":"2","author":"X Liu","year":"2021","unstructured":"Liu X, Xie X, Ren Y et al (2021) The role of necroptosis in disease and treatment. MedComm 2:730\u2013755. https:\/\/doi.org\/10.1002\/mco2.108","journal-title":"MedComm"},{"key":"2260_CR19","doi-asserted-by":"crossref","unstructured":"Park H, Kam T-I, Dawson TM, Dawson VL (2020) Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases. In: International Review of Cell and Molecular Biology. pp 1\u201329","DOI":"10.1016\/bs.ircmb.2019.12.009"},{"key":"2260_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR (2023) The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov 22:723\u2013742. https:\/\/doi.org\/10.1038\/s41573-023-00749-8","journal-title":"Nat Rev Drug Discov"},{"key":"2260_CR21","doi-asserted-by":"publisher","first-page":"9947","DOI":"10.3390\/ijms25189947","volume":"25","author":"D Guo","year":"2024","unstructured":"Guo D, Liu Z, Zhou J et al (2024) Significance of programmed cell death pathways in neurodegenerative diseases. Int J Mol Sci 25:9947. https:\/\/doi.org\/10.3390\/ijms25189947","journal-title":"Int J Mol Sci"},{"key":"2260_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jare.2024.04.031","volume":"70","author":"J Zhang","year":"2025","unstructured":"Zhang J, Hu X, Geng Y et al (2025) Exploring the role of parthanatos in CNS injury: molecular insights and therapeutic approaches. J Adv Res 70:271\u2013286. https:\/\/doi.org\/10.1016\/j.jare.2024.04.031","journal-title":"J Adv Res"},{"key":"2260_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-024-01801-8","volume":"9","author":"C Zhu","year":"2024","unstructured":"Zhu C, Xu S, Jiang R et al (2024) The gasdermin family: emerging therapeutic targets in diseases. Signal Transduct Target Ther 9:87. https:\/\/doi.org\/10.1038\/s41392-024-01801-8","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/etm.2022.11230","volume":"23","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li H, Wang W, Li H (2022) Assessing the anti\u2013inflammatory effects of Quercetin using network Pharmacology and in vitro experiments. Exp Ther Med 23:301. https:\/\/doi.org\/10.3892\/etm.2022.11230","journal-title":"Exp Ther Med"},{"key":"2260_CR25","doi-asserted-by":"publisher","first-page":"104961","DOI":"10.1016\/j.neubiorev.2022.104961","volume":"144","author":"MU Rehman","year":"2023","unstructured":"Rehman MU, Sehar N, Dar NJ et al (2023) Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments. Neurosci Biobehav Rev 144:104961. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104961","journal-title":"Neurosci Biobehav Rev"},{"key":"2260_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","volume":"19","author":"J Cui","year":"2021","unstructured":"Cui J, Zhao S, Li Y et al (2021) Regulated cell death: discovery, features and implications for neurodegenerative diseases. Cell Commun Signal 19:120. https:\/\/doi.org\/10.1186\/s12964-021-00799-8","journal-title":"Cell Commun Signal"},{"key":"2260_CR27","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11033-022-08048-y","volume":"50","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zhao J, Zhao Y et al (2023) The role of ferroptosis in neurodegenerative diseases. Mol Biol Rep 50:1655\u20131661. https:\/\/doi.org\/10.1007\/s11033-022-08048-y","journal-title":"Mol Biol Rep"},{"key":"2260_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N et al (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6:128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR29","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.arr.2023.102078","volume":"91","author":"M-L Hu","year":"2023","unstructured":"Hu M-L, Pan Y-R, Yong Y-Y et al (2023) Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future. Ageing Res Rev 91:102078. https:\/\/doi.org\/10.1016\/j.arr.2023.102078","journal-title":"Ageing Res Rev"},{"key":"2260_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41419-024-07244-x","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Sun J, Luo Z et al (2024) Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death Dis 15:859. https:\/\/doi.org\/10.1038\/s41419-024-07244-x","journal-title":"Cell Death Dis"},{"key":"2260_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2260_CR32","doi-asserted-by":"publisher","unstructured":"Lin Z, Liu J, Kang R et al (2021) Lipid metabolism in ferroptosis. Adv Biol 5. https:\/\/doi.org\/10.1002\/adbi.202100396","DOI":"10.1002\/adbi.202100396"},{"key":"2260_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/biology10030184","volume":"10","author":"J-Y Lee","year":"2021","unstructured":"Lee J-Y, Kim WK, Bae K-H et al (2021) Lipid metabolism and ferroptosis. Biology (Basel) 10:184. https:\/\/doi.org\/10.3390\/biology10030184","journal-title":"Biology (Basel)"},{"key":"2260_CR34","doi-asserted-by":"publisher","unstructured":"Hu X, Xu Y, Xu H et al (2021) Progress in Understanding ferroptosis and its targeting for therapeutic benefits in traumatic brain and spinal cord injuries. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.705786","DOI":"10.3389\/fcell.2021.705786"},{"key":"2260_CR35","doi-asserted-by":"publisher","unstructured":"Zhai Z, Zou P, Liu F et al (2021) Ferroptosis is a potential novel diagnostic and therapeutic target for patients with cardiomyopathy. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.649045","DOI":"10.3389\/fcell.2021.649045"},{"key":"2260_CR36","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D (2022) Signaling pathways and defense mechanisms of ferroptosis. FEBS J 289:7038\u20137050. https:\/\/doi.org\/10.1111\/febs.16059","journal-title":"FEBS J"},{"key":"2260_CR37","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.redox.2020.101494","volume":"32","author":"A Ashraf","year":"2020","unstructured":"Ashraf A, Jeandriens J, Parkes HG, So P-W (2020) Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in alzheimer\u2019s disease: evidence of ferroptosis. Redox Biol 32:101494. https:\/\/doi.org\/10.1016\/j.redox.2020.101494","journal-title":"Redox Biol"},{"key":"2260_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/cbf.3581","volume":"39","author":"L Liu","year":"2021","unstructured":"Liu L, Liu R, Liu Y et al (2021) Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Cell Biochem Funct 39:174\u2013179. https:\/\/doi.org\/10.1002\/cbf.3581","journal-title":"Cell Biochem Funct"},{"key":"2260_CR39","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/jnr.25033","volume":"100","author":"H Long","year":"2022","unstructured":"Long H, Cheng Y, Zhou Z et al (2022) The key roles of organelles and ferroptosis in Alzheimer\u02bcs disease. J Neurosci Res 100:1257\u20131280. https:\/\/doi.org\/10.1002\/jnr.25033","journal-title":"J Neurosci Res"},{"key":"2260_CR40","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.7150\/ijbs.72251","volume":"18","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tang B, Zhu J et al (2022) Emerging mechanisms and targeted therapy of ferroptosis in neurological diseases and Neuro-oncology. Int J Biol Sci 18:4260\u20134274. https:\/\/doi.org\/10.7150\/ijbs.72251","journal-title":"Int J Biol Sci"},{"key":"2260_CR41","doi-asserted-by":"publisher","unstructured":"Vitalakumar D, Sharma A, Flora SJS (2021) Ferroptosis: A potential therapeutic target for neurodegenerative diseases. J Biochem Mol Toxicol 35. https:\/\/doi.org\/10.1002\/jbt.22830","DOI":"10.1002\/jbt.22830"},{"key":"2260_CR42","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.3390\/ijms22189902","volume":"22","author":"X Wang","year":"2021","unstructured":"Wang X, Wang Z, Cao J et al (2021) Ferroptosis mechanisms involved in Hippocampal-Related diseases. Int J Mol Sci 22:9902. https:\/\/doi.org\/10.3390\/ijms22189902","journal-title":"Int J Mol Sci"},{"key":"2260_CR43","doi-asserted-by":"publisher","unstructured":"Soni P, Ammal Kaidery N, Sharma SM et al (2024) A critical appraisal of ferroptosis in alzheimer\u2019s and parkinson\u2019s disease: new insights into emerging mechanisms and therapeutic targets. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/fphar.2024.1390798","DOI":"10.3389\/fphar.2024.1390798"},{"key":"2260_CR44","doi-asserted-by":"publisher","unstructured":"Smith K, Colie M, Moore T, Schisler JC (2024) Die hard: necroptosis and its impact on age-dependent neuroinflammatory diseases. Front Cell Death 3. https:\/\/doi.org\/10.3389\/fceld.2024.1348153","DOI":"10.3389\/fceld.2024.1348153"},{"key":"2260_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41419-023-05691-6","volume":"14","author":"K Ye","year":"2023","unstructured":"Ye K, Chen Z, Xu Y (2023) The double-edged functions of necroptosis. Cell Death Dis 14:163. https:\/\/doi.org\/10.1038\/s41419-023-05691-6","journal-title":"Cell Death Dis"},{"key":"2260_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G et al (2019) The role of necroptosis in cancer biology and therapy. Mol Cancer 18:100. https:\/\/doi.org\/10.1186\/s12943-019-1029-8","journal-title":"Mol Cancer"},{"key":"2260_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jmcb\/mjaa055","volume":"13","author":"L Li","year":"2021","unstructured":"Li L, Tong A, Zhang Q et al (2021) The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis. J Mol Cell Biol 13:3\u201314. https:\/\/doi.org\/10.1093\/jmcb\/mjaa055","journal-title":"J Mol Cell Biol"},{"key":"2260_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-022-01332-9","volume":"10","author":"N Salvadores","year":"2022","unstructured":"Salvadores N, Moreno-Gonzalez I, Gamez N et al (2022) A\u03b2 oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in alzheimer\u2019s disease. Acta Neuropathol Commun 10:31. https:\/\/doi.org\/10.1186\/s40478-022-01332-9","journal-title":"Acta Neuropathol Commun"},{"key":"2260_CR49","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.7150\/thno.62376","volume":"11","author":"C Xu","year":"2021","unstructured":"Xu C, Wu J, Wu Y et al (2021) TNF-\u03b1-dependent neuronal necroptosis regulated in alzheimer\u2019s disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Theranostics 11:9452\u20139469. https:\/\/doi.org\/10.7150\/thno.62376","journal-title":"Theranostics"},{"key":"2260_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13195-024-01649-8","volume":"16","author":"E Carrazana","year":"2024","unstructured":"Carrazana E, Salvadores N (2024) Therapeutic implications of necroptosis activation in Alzheimer\u00b4s disease. Alzheimers Res Ther 16:275. https:\/\/doi.org\/10.1186\/s13195-024-01649-8","journal-title":"Alzheimers Res Ther"},{"key":"2260_CR51","doi-asserted-by":"publisher","unstructured":"Moonen S, Koper MJ, Ronisz A et al (2024) The Inhibition of necroptosis prevents neuronal death in a mouse model of alzheimer\u2019s disease pathology. Alzheimer\u2019s Dement 20. https:\/\/doi.org\/10.1002\/alz.087322","DOI":"10.1002\/alz.087322"},{"key":"2260_CR52","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.3390\/ijms22105289","volume":"22","author":"S Oliveira","year":"2021","unstructured":"Oliveira S, Dion\u00edsio P, Gaspar M et al (2021) Discovery of a necroptosis inhibitor improving dopaminergic neuronal loss after MPTP exposure in mice. Int J Mol Sci 22:5289. https:\/\/doi.org\/10.3390\/ijms22105289","journal-title":"Int J Mol Sci"},{"key":"2260_CR53","doi-asserted-by":"publisher","unstructured":"Qiu Y, Cheng L, Xiong Y et al (2025) Advances in the study of necroptosis in vascular dementia: focus on Blood\u2013Brain barrier and neuroinflammation. https:\/\/doi.org\/10.1111\/cns.70224. CNS Neurosci Ther 31:","DOI":"10.1111\/cns.70224"},{"key":"2260_CR54","doi-asserted-by":"publisher","unstructured":"Tao Y, Murakami Y, Vavvas DG, Sonoda K-H (2022) Necroptosis and neuroinflammation in retinal degeneration. Front Neurosci 16. https:\/\/doi.org\/10.3389\/fnins.2022.911430","DOI":"10.3389\/fnins.2022.911430"},{"key":"2260_CR55","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/antiox10101518","volume":"10","author":"D Jantas","year":"2021","unstructured":"Jantas D, Laso\u0144 W (2021) Preclinical evidence for the interplay between oxidative stress and RIP1-Dependent cell death in neurodegeneration: state of the Art and possible therapeutic implications. Antioxidants 10:1518. https:\/\/doi.org\/10.3390\/antiox10101518","journal-title":"Antioxidants"},{"key":"2260_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","volume":"147","author":"S Balusu","year":"2024","unstructured":"Balusu S, De Strooper B (2024) The necroptosis cell death pathway drives neurodegeneration in alzheimer\u2019s disease. Acta Neuropathol 147:96. https:\/\/doi.org\/10.1007\/s00401-024-02747-5","journal-title":"Acta Neuropathol"},{"key":"2260_CR58","doi-asserted-by":"publisher","unstructured":"Chen K, Wang S, Lei H, Liu X (2024) Necrostatin-1: a promising compound for neurological disorders. Front Cell Neurosci 18. https:\/\/doi.org\/10.3389\/fncel.2024.1408364","DOI":"10.3389\/fncel.2024.1408364"},{"key":"2260_CR59","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1021\/acschemneuro.2c00172","volume":"13","author":"W Zhao","year":"2022","unstructured":"Zhao W, Liu Y, Xu L et al (2022) Targeting necroptosis as a promising therapy for alzheimer\u2019s disease. ACS Chem Neurosci 13:1697\u20131713. https:\/\/doi.org\/10.1021\/acschemneuro.2c00172","journal-title":"ACS Chem Neurosci"},{"key":"2260_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/mmr.2024.13259","volume":"30","author":"Z Jia","year":"2024","unstructured":"Jia Z, Zhang X, Li Z et al (2024) Hydrogen sulfide mitigates ox\u2013LDL\u2013induced NLRP3\/caspase\u20131\/GSDMD dependent macrophage pyroptosis by S\u2013sulfhydrating caspase\u20131. Mol Med Rep 30:135. https:\/\/doi.org\/10.3892\/mmr.2024.13259","journal-title":"Mol Med Rep"},{"key":"2260_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15698\/cst2022.10.272","volume":"6","author":"X Zeng","year":"2022","unstructured":"Zeng X, Liu D, Huo X et al (2022) Pyroptosis in NLRP3 inflammasome-related atherosclerosis. Cell Stress 6:79\u201388. https:\/\/doi.org\/10.15698\/cst2022.10.272","journal-title":"Cell Stress"},{"key":"2260_CR62","doi-asserted-by":"publisher","first-page":"16115","DOI":"10.3390\/ijms232416115","volume":"23","author":"S Wei","year":"2022","unstructured":"Wei S, Feng M, Zhang S (2022) Molecular characteristics of cell pyroptosis and its inhibitors: A review of Activation, Regulation, and inhibitors. Int J Mol Sci 23:16115. https:\/\/doi.org\/10.3390\/ijms232416115","journal-title":"Int J Mol Sci"},{"key":"2260_CR63","doi-asserted-by":"publisher","first-page":"571810","DOI":"10.3389\/fphys.2020.571810","volume":"11","author":"S Zhao","year":"2020","unstructured":"Zhao S, Chen F, Yin Q et al (2020) Reactive oxygen species interact with NLRP3 inflammasomes and are involved in the inflammation of sepsis: from mechanism to treatment of progression. Front Physiol 11:571810. https:\/\/doi.org\/10.3389\/fphys.2020.571810","journal-title":"Front Physiol"},{"key":"2260_CR64","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ars.2020.8257","volume":"36","author":"A Dominic","year":"2022","unstructured":"Dominic A, Le N-T, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal 36:784\u2013796. https:\/\/doi.org\/10.1089\/ars.2020.8257","journal-title":"Antioxid Redox Signal"},{"key":"2260_CR65","doi-asserted-by":"publisher","unstructured":"Yang L, Zhang Y, Chai Z et al (2025) Regulation of pyroptosis by NF-\u03baB signaling. Front Cell Death 3. https:\/\/doi.org\/10.3389\/fceld.2024.1503799","DOI":"10.3389\/fceld.2024.1503799"},{"key":"2260_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/08830185.2022.2052064","volume":"42","author":"M Yue","year":"2023","unstructured":"Yue M, Xiao L, Yan R et al (2023) Pyroptosis in neurodegenerative diseases: what Lies beneath the tip of the iceberg? Int Rev Immunol 42:258\u2013273. https:\/\/doi.org\/10.1080\/08830185.2022.2052064","journal-title":"Int Rev Immunol"},{"key":"2260_CR67","doi-asserted-by":"publisher","unstructured":"Jin X, Ma Y, Liu D, Huang Y (2023) Role of pyroptosis in the pathogenesis and treatment of diseases. https:\/\/doi.org\/10.1002\/mco2.249. MedComm 4:","DOI":"10.1002\/mco2.249"},{"key":"2260_CR68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","volume":"119","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Wang B et al (2024) Pyroptosis-mediator GSDMD promotes parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death. Brain Behav Immun 119:129\u2013145. https:\/\/doi.org\/10.1016\/j.bbi.2024.03.038","journal-title":"Brain Behav Immun"},{"key":"2260_CR69","doi-asserted-by":"publisher","unstructured":"Brokatzky D, Mostowy S (2022) Pyroptosis in host defence against bacterial infection. Dis Model Mech 15. https:\/\/doi.org\/10.1242\/dmm.049414","DOI":"10.1242\/dmm.049414"},{"key":"2260_CR70","doi-asserted-by":"publisher","unstructured":"Ju Y, Zhao L, Li S, Zhao Q (2023) The role of pyroptosis in alzheimer\u2019s disease. J Integr Neurosci 22. https:\/\/doi.org\/10.31083\/j.jin2205129","DOI":"10.31083\/j.jin2205129"},{"key":"2260_CR71","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3233\/JPD-223338","volume":"12","author":"S Jewell","year":"2022","unstructured":"Jewell S, Herath AM, Gordon R (2022) Inflammasome activation in parkinson\u2019s disease. J Parkinsons Dis 12:S113\u2013S128. https:\/\/doi.org\/10.3233\/JPD-223338","journal-title":"J Parkinsons Dis"},{"key":"2260_CR72","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms23158363","volume":"23","author":"E Paldino","year":"2022","unstructured":"Paldino E, Fusco FR (2022) Emerging role of NLRP3 Inflammasome\/Pyroptosis in huntington\u2019s disease. Int J Mol Sci 23:8363. https:\/\/doi.org\/10.3390\/ijms23158363","journal-title":"Int J Mol Sci"},{"key":"2260_CR73","doi-asserted-by":"publisher","unstructured":"Huang Y, Li X, Luo G et al (2022) Pyroptosis as a candidate therapeutic target for alzheimer\u2019s disease. Front Aging Neurosci 14. https:\/\/doi.org\/10.3389\/fnagi.2022.996646","DOI":"10.3389\/fnagi.2022.996646"},{"key":"2260_CR74","doi-asserted-by":"publisher","unstructured":"McKenzie B, Mamik M, Saito L et al (2018) Live or let die: pyroptosis and inflammasome activation in glial cells during multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 200 45.50\u201345.50. https:\/\/doi.org\/10.4049\/jimmunol.200.Supp.45.50","DOI":"10.4049\/jimmunol.200.Supp.45.50"},{"key":"2260_CR75","doi-asserted-by":"publisher","unstructured":"Cui Y, Yu H, Bu Z et al (2022) Focus on the role of the NLRP3 inflammasome in multiple sclerosis: Pathogenesis, Diagnosis, and therapeutics. Front Mol Neurosci 15. https:\/\/doi.org\/10.3389\/fnmol.2022.894298","DOI":"10.3389\/fnmol.2022.894298"},{"key":"2260_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-021-04109-w","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Li J, Ke Y et al (2022) The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis. Cell Mol Life Sci 79:60. https:\/\/doi.org\/10.1007\/s00018-021-04109-w","journal-title":"Cell Mol Life Sci"},{"key":"2260_CR77","doi-asserted-by":"publisher","unstructured":"Huang P, Chen G, Jin W et al (2022) Molecular mechanisms of parthanatos and its role in diverse diseases. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23137292","DOI":"10.3390\/ijms23137292"},{"key":"2260_CR78","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/cns.13934","volume":"28","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang W, Ge P et al (2022) Parthanatos participates in glutamate-mediated HT22 cell injury and hippocampal neuronal death in Kainic acid\u2010induced status epilepticus rats. CNS Neurosci Ther 28:2032\u20132043. https:\/\/doi.org\/10.1111\/cns.13934","journal-title":"CNS Neurosci Ther"},{"key":"2260_CR79","doi-asserted-by":"publisher","first-page":"106314","DOI":"10.1016\/j.nbd.2023.106314","volume":"187","author":"X Xu","year":"2023","unstructured":"Xu X, Sun B, Zhao C (2023) Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: from pathogenesis to therapeutic opportunities. Neurobiol Dis 187:106314. https:\/\/doi.org\/10.1016\/j.nbd.2023.106314","journal-title":"Neurobiol Dis"},{"key":"2260_CR80","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.2387","volume":"17","author":"SA Andrabi","year":"2011","unstructured":"Andrabi SA, Kang HC, Haince J-F et al (2011) Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat Med 17:692\u2013699. https:\/\/doi.org\/10.1038\/nm.2387","journal-title":"Nat Med"},{"key":"2260_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.15464","volume":"160","author":"S Liu","year":"2022","unstructured":"Liu S, Luo W, Wang Y (2022) Emerging role of PARP-1 and parthanatos in ischemic stroke. J Neurochem 160:74\u201387. https:\/\/doi.org\/10.1111\/jnc.15464","journal-title":"J Neurochem"},{"key":"2260_CR82","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/15376516.2022.2053254","volume":"32","author":"D Zhu","year":"2022","unstructured":"Zhu D, Liang R, Liu Y et al (2022) Deferoxamine ameliorated Al(mal) 3 -induced neuronal ferroptosis in adult rats by chelating brain iron to attenuate oxidative damage. Toxicol Mech Methods 32:530\u2013541. https:\/\/doi.org\/10.1080\/15376516.2022.2053254","journal-title":"Toxicol Mech Methods"},{"key":"2260_CR83","doi-asserted-by":"publisher","first-page":"176765","DOI":"10.1016\/j.ejphar.2024.176765","volume":"978","author":"Y Han","year":"2024","unstructured":"Han Y, Wang C, Li X, Liang G (2024) PARP-1 dependent cell death pathway (Parthanatos) mediates early brain injury after subarachnoid hemorrhage. Eur J Pharmacol 978:176765. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176765","journal-title":"Eur J Pharmacol"},{"key":"2260_CR84","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.bcp.2024.116174","volume":"228","author":"L Yang","year":"2024","unstructured":"Yang L, Guttman L, Dawson VL, Dawson TM (2024) Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem Pharmacol 228:116174. https:\/\/doi.org\/10.1016\/j.bcp.2024.116174","journal-title":"Biochem Pharmacol"},{"key":"2260_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13557","volume":"32","author":"H Zeng","year":"2025","unstructured":"Zeng H, Jin Z (2025) The role of ferroptosis in alzheimer\u2019s disease: mechanisms and therapeutic potential (Review). Mol Med Rep 32:1\u201310. https:\/\/doi.org\/10.3892\/mmr.2025.13557","journal-title":"Mol Med Rep"},{"key":"2260_CR86","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.4103\/1673-5374.391311","volume":"19","author":"B Hu","year":"2024","unstructured":"Hu B, Zhang J, Huang J et al (2024) NLRP3\/1-mediated pyroptosis: beneficial clues for the development of novel therapies for alzheimer\u2019s disease. Neural Regen Res 19:2400\u20132410. https:\/\/doi.org\/10.4103\/1673-5374.391311","journal-title":"Neural Regen Res"},{"key":"2260_CR87","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s42003-024-06552-4","volume":"7","author":"MK Foret","year":"2024","unstructured":"Foret MK, Orciani C, Welikovitch LA et al (2024) Early oxidative stress and DNA damage in A\u03b2-burdened hippocampal neurons in an Alzheimer\u2019s-like Transgenic rat model. Commun Biol 7:861. https:\/\/doi.org\/10.1038\/s42003-024-06552-4","journal-title":"Commun Biol"},{"key":"2260_CR88","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/brain\/awr104","volume":"134","author":"R Abeti","year":"2011","unstructured":"Abeti R, Abramov AY, Duchen MR (2011) \u03b2-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134:1658\u20131672. https:\/\/doi.org\/10.1093\/brain\/awr104","journal-title":"Brain"},{"key":"2260_CR89","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/febs.15716","volume":"289","author":"K Mao","year":"2022","unstructured":"Mao K, Zhang G (2022) The role of PARP1 in neurodegenerative diseases and aging. FEBS J 289:2013\u20132024. https:\/\/doi.org\/10.1111\/febs.15716","journal-title":"FEBS J"},{"key":"2260_CR90","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.3390\/ijms252313042","volume":"25","author":"M Zhou","year":"2024","unstructured":"Zhou M, Xu K, Ge J et al (2024) Targeting ferroptosis in parkinson\u2019s disease: mechanisms and emerging therapeutic strategies. Int J Mol Sci 25:13042. https:\/\/doi.org\/10.3390\/ijms252313042","journal-title":"Int J Mol Sci"},{"key":"2260_CR91","doi-asserted-by":"publisher","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"X Ding","year":"2023","unstructured":"Ding X, Gao L, Han Z et al (2023) Ferroptosis in parkinson\u2019s disease: molecular mechanisms and therapeutic potential. Ageing Res Rev 91:102077. https:\/\/doi.org\/10.1016\/j.arr.2023.102077","journal-title":"Ageing Res Rev"},{"key":"2260_CR92","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/ejn.16136","volume":"59","author":"M Regoni","year":"2024","unstructured":"Regoni M, Valtorta F, Sassone J (2024) Dopaminergic neuronal death via necroptosis in parkinson\u2019s disease: A review of the literature. Eur J Neurosci 59:1079\u20131098. https:\/\/doi.org\/10.1111\/ejn.16136","journal-title":"Eur J Neurosci"},{"key":"2260_CR93","doi-asserted-by":"publisher","first-page":"e28838","DOI":"10.1016\/j.heliyon.2024.e28838","volume":"10","author":"J Yu","year":"2024","unstructured":"Yu J, Zhao Z, Li Y et al (2024) Role of NLRP3 in parkinson\u2019s disease: specific activation especially in dopaminergic neurons. Heliyon 10:e28838. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28838","journal-title":"Heliyon"},{"key":"2260_CR94","doi-asserted-by":"publisher","unstructured":"Hu J, Wu J, Wan F et al (2021) Calcitriol alleviates MPP+- and MPTP-Induced parthanatos through the VDR\/PARP1 pathway in the model of parkinson\u2019s disease. Front Aging Neurosci 13. https:\/\/doi.org\/10.3389\/fnagi.2021.657095","DOI":"10.3389\/fnagi.2021.657095"},{"key":"2260_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.04.020","author":"H Park","year":"2022","unstructured":"Park H, Kam T-I, Peng H et al (2022) PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson\u2019s disease. Cell 185. https:\/\/doi.org\/10.1016\/j.cell.2022.04.020. :1943\u20131959.e21"},{"key":"2260_CR96","doi-asserted-by":"publisher","unstructured":"de Moura RD, de Mattos PD, Valente PF, Hoch NC (2024) Molecular mechanisms of cell death by parthanatos: more questions than answers. Genet Mol Biol 47. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2023-0357","DOI":"10.1590\/1678-4685-gmb-2023-0357"},{"key":"2260_CR97","doi-asserted-by":"publisher","first-page":"103450","DOI":"10.1016\/j.nicl.2023.103450","volume":"39","author":"NA van de Zande","year":"2023","unstructured":"van de Zande NA, Bulk M, Najac C et al (2023) Study protocol of IMAGINE-HD: imaging iron accumulation and neuroinflammation with 7T-MRI\u2009+\u2009CSF in huntington\u2019s disease. NeuroImage Clin 39:103450. https:\/\/doi.org\/10.1016\/j.nicl.2023.103450","journal-title":"NeuroImage Clin"},{"key":"2260_CR98","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1101\/gad.350211.122","volume":"37","author":"S Song","year":"2023","unstructured":"Song S, Su Z, Kon N et al (2023) ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in huntington\u2019s disease. Genes Dev 37:204\u2013217. https:\/\/doi.org\/10.1101\/gad.350211.122","journal-title":"Genes Dev"},{"key":"2260_CR99","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/jmri.29195","volume":"60","author":"J Yao","year":"2024","unstructured":"Yao J, Morrison MA, Jakary A et al (2024) Altered iron and microstructure in huntington\u2019s disease subcortical nuclei: insight from 7T MRI. J Magn Reson Imaging 60:1484\u20131499. https:\/\/doi.org\/10.1002\/jmri.29195","journal-title":"J Magn Reson Imaging"},{"key":"2260_CR100","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s10020-025-01172-y","volume":"31","author":"EM Elbaz","year":"2025","unstructured":"Elbaz EM, Sayed RH, Abdelkader AA, Fahim AT (2025) Neuroprotective role of Morin hydrate on 3-nitropropionic acid-elicited huntington\u2019s disease: in vivo investigation of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway. Mol Med 31:135. https:\/\/doi.org\/10.1186\/s10020-025-01172-y","journal-title":"Mol Med"},{"key":"2260_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41420-020-00293-z","volume":"6","author":"E Paldino","year":"2020","unstructured":"Paldino E, D\u2019Angelo V, Sancesario G, Fusco FR (2020) Pyroptotic cell death in the R6\/2 mouse model of huntington\u2019s disease: new insight on the inflammasome. Cell Death Discov 6:69. https:\/\/doi.org\/10.1038\/s41420-020-00293-z","journal-title":"Cell Death Discov"},{"key":"2260_CR102","doi-asserted-by":"publisher","unstructured":"Maiuri T, Bazan CB, Harding RJ et al (2024) Poly ADP-ribose signaling is dysregulated in huntington disease. Proc Natl Acad Sci 121. https:\/\/doi.org\/10.1073\/pnas.2318098121","DOI":"10.1073\/pnas.2318098121"},{"key":"2260_CR103","doi-asserted-by":"publisher","DOI":"10.1177\/18796397251372667","author":"C Peng","year":"2025","unstructured":"Peng C, Maiuri T, Truant R (2025) Tipping the parylation scale: dysregulation of PAR signaling in huntington and neurodegenerative diseases. J Huntingtons Dis. https:\/\/doi.org\/10.1177\/18796397251372667","journal-title":"J Huntingtons Dis"},{"key":"2260_CR104","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","volume":"29","author":"T Wang","year":"2022","unstructured":"Wang T, Tomas D, Perera ND et al (2022) Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ 29:1187\u20131198. https:\/\/doi.org\/10.1038\/s41418-021-00910-z","journal-title":"Cell Death Differ"},{"key":"2260_CR105","doi-asserted-by":"publisher","unstructured":"Peng J, Pan J, Mo J, Peng Y (2022) MPO\/HOCl facilitates apoptosis and ferroptosis in the SOD1 G93A motor neuron of amyotrophic lateral sclerosis. https:\/\/doi.org\/10.1155\/2022\/8217663. Oxid Med Cell Longev 2022:","DOI":"10.1155\/2022\/8217663"},{"key":"2260_CR106","doi-asserted-by":"publisher","unstructured":"Mifflin L, Hu Z, Dufort C et al (2021) A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis. Proc Natl Acad Sci 118. https:\/\/doi.org\/10.1073\/pnas.2025102118","DOI":"10.1073\/pnas.2025102118"},{"key":"2260_CR107","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/cells13120995","volume":"13","author":"H Cihankaya","year":"2024","unstructured":"Cihankaya H, Bader V, Winklhofer KF et al (2024) Elevated NLRP3 inflammasome activation is associated with motor neuron degeneration in ALS. Cells 13:995. https:\/\/doi.org\/10.3390\/cells13120995","journal-title":"Cells"},{"key":"2260_CR108","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann S, Heitzer M, Kanagaratnam M et al (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63:2260\u20132273. https:\/\/doi.org\/10.1002\/glia.22891","journal-title":"Glia"},{"key":"2260_CR109","doi-asserted-by":"crossref","unstructured":"Gunner G, Basu H, Lu Y et al (2024) Gasdermin D is activated but does not drive neurodegeneration in SOD1 G93A model of ALS. Implications for targeting pyroptosis","DOI":"10.1016\/j.nbd.2025.107048"},{"key":"2260_CR110","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","volume":"6","author":"L McGurk","year":"2018","unstructured":"McGurk L, Mojsilovic-Petrovic J, Van Deerlin VM et al (2018) Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis. Acta Neuropathol Commun 6:84. https:\/\/doi.org\/10.1186\/s40478-018-0586-1","journal-title":"Acta Neuropathol Commun"},{"key":"2260_CR111","doi-asserted-by":"publisher","unstructured":"Zhou B, Li J, Wu A et al (2025) Insights into targeted ferroptosis in mechanisms, biology, and role of alzheimer\u2019s disease: an update. Front Aging Neurosci 17. https:\/\/doi.org\/10.3389\/fnagi.2025.1587986","DOI":"10.3389\/fnagi.2025.1587986"},{"key":"2260_CR112","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cbin.11505","volume":"45","author":"L Liu","year":"2021","unstructured":"Liu L, Yang S, Wang H (2021) \u03b1-Lipoic acid alleviates ferroptosis in the MPP + \u2010induced PC12 cells via activating the PI3K\/Akt\/Nrf2 pathway. Cell Biol Int 45:422\u2013431. https:\/\/doi.org\/10.1002\/cbin.11505","journal-title":"Cell Biol Int"},{"key":"2260_CR113","doi-asserted-by":"publisher","unstructured":"Wang Y, Wu S, Li Q et al (2023) Pharmacological Inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv Sci 10. https:\/\/doi.org\/10.1002\/advs.202300325","DOI":"10.1002\/advs.202300325"},{"key":"2260_CR114","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3390\/molecules30143020","volume":"30","author":"M Paw\u0142owska","year":"2025","unstructured":"Paw\u0142owska M, Nuszkiewicz J, Jarek DJ, Wo\u017aniak A (2025) Ferroptosis and metabolic dysregulation: emerging chemical targets in cancer and infection. Molecules 30:3020. https:\/\/doi.org\/10.3390\/molecules30143020","journal-title":"Molecules"},{"key":"2260_CR115","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3390\/ijms22094479","volume":"22","author":"E Ficiar\u00e0","year":"2021","unstructured":"Ficiar\u00e0 E, Munir Z, Boschi S et al (2021) Alteration of iron concentration in alzheimer\u2019s disease as a possible diagnostic biomarker unveiling ferroptosis. Int J Mol Sci 22:4479. https:\/\/doi.org\/10.3390\/ijms22094479","journal-title":"Int J Mol Sci"},{"key":"2260_CR116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12868-019-0505-9","volume":"20","author":"Q Chen","year":"2019","unstructured":"Chen Q, Chen Y, Zhang Y et al (2019) Iron deposition in parkinson\u2019s disease by quantitative susceptibility mapping. BMC Neurosci 20:23. https:\/\/doi.org\/10.1186\/s12868-019-0505-9","journal-title":"BMC Neurosci"},{"key":"2260_CR117","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1007\/s12559-022-10095-3","volume":"16","author":"S Verma","year":"2024","unstructured":"Verma S, Goel T, Tanveer M (2024) Quantitative susceptibility mapping in cognitive decline: A review of technical aspects and applications. Cognit Comput 16:1992\u20132008. https:\/\/doi.org\/10.1007\/s12559-022-10095-3","journal-title":"Cognit Comput"},{"key":"2260_CR118","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"W-D Bao","year":"2021","unstructured":"Bao W-D, Pang P, Zhou X-T et al (2021) Loss of Ferroportin induces memory impairment by promoting ferroptosis in alzheimer\u2019s disease. Cell Death Differ 28:1548\u20131562. https:\/\/doi.org\/10.1038\/s41418-020-00685-9","journal-title":"Cell Death Differ"},{"key":"2260_CR119","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","volume":"19","author":"JR Liddell","year":"2024","unstructured":"Liddell JR, Hilton JBW, Kysenius K et al (2024) Microglial ferroptotic stress causes non-cell autonomous neuronal death. Mol Neurodegener 19:14. https:\/\/doi.org\/10.1186\/s13024-023-00691-8","journal-title":"Mol Neurodegener"},{"key":"2260_CR120","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12915-025-02235-6","volume":"23","author":"A Currais","year":"2025","unstructured":"Currais A, Sanchez K, Soriano-Castell D et al (2025) Transcriptomic signatures of oxytosis\/ferroptosis are enriched in alzheimer\u2019s disease. BMC Biol 23:132. https:\/\/doi.org\/10.1186\/s12915-025-02235-6","journal-title":"BMC Biol"},{"key":"2260_CR121","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ph15101177","volume":"15","author":"Y Dang","year":"2022","unstructured":"Dang Y, He Q, Yang S et al (2022) FTH1- and SAT1-Induced astrocytic ferroptosis is involved in alzheimer\u2019s disease: evidence from Single-Cell transcriptomic analysis. Pharmaceuticals 15:1177. https:\/\/doi.org\/10.3390\/ph15101177","journal-title":"Pharmaceuticals"},{"key":"2260_CR122","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper MJ, Van Schoor E, Ospitalieri S et al (2020) Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in alzheimer\u2019s disease. Acta Neuropathol 139:463\u2013484. https:\/\/doi.org\/10.1007\/s00401-019-02103-y","journal-title":"Acta Neuropathol"},{"key":"2260_CR123","doi-asserted-by":"publisher","unstructured":"Maelfait J, Rehwinkel J (2023) The Z-nucleic acid sensor ZBP1 in health and disease. J Exp Med 220. https:\/\/doi.org\/10.1084\/jem.20221156","DOI":"10.1084\/jem.20221156"},{"key":"2260_CR124","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.3390\/ijms241210108","volume":"24","author":"V Martinez-Osorio","year":"2023","unstructured":"Martinez-Osorio V, Abdelwahab Y, Ros U (2023) The many faces of MLKL, the executor of necroptosis. Int J Mol Sci 24:10108. https:\/\/doi.org\/10.3390\/ijms241210108","journal-title":"Int J Mol Sci"},{"key":"2260_CR125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D (2022) The mechanism of HMGB1 secretion and release. Exp Mol Med 54:91\u2013102. https:\/\/doi.org\/10.1038\/s12276-022-00736-w","journal-title":"Exp Mol Med"},{"key":"2260_CR126","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan R, Ouyang Y et al (2024) Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Signal Transduct Target Ther 9:245. https:\/\/doi.org\/10.1038\/s41392-024-01958-2","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR127","doi-asserted-by":"publisher","first-page":"12209","DOI":"10.18632\/aging.205174","volume":"15","author":"W Hong","year":"2023","unstructured":"Hong W, Hu C, Wang C et al (2023) Effects of amyloid \u03b2 (A\u03b2)42 and gasdermin D on the progression of alzheimer\u2019s disease in vitro and in vivo through the regulation of astrocyte pyroptosis. Aging 15:12209\u201312224. https:\/\/doi.org\/10.18632\/aging.205174","journal-title":"Aging"},{"key":"2260_CR128","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10571-025-01579-5","volume":"45","author":"T Tang","year":"2025","unstructured":"Tang T (2025) Pyroptosis in alzheimer\u2019s disease: mechanisms and therapeutic potential. Cell Mol Neurobiol 45:57. https:\/\/doi.org\/10.1007\/s10571-025-01579-5","journal-title":"Cell Mol Neurobiol"},{"key":"2260_CR129","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-021-02329-2","volume":"18","author":"W Rui","year":"2021","unstructured":"Rui W, Xiao H, Fan Y et al (2021) Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and alzheimer\u2019s disease. J Neuroinflammation 18:280. https:\/\/doi.org\/10.1186\/s12974-021-02329-2","journal-title":"J Neuroinflammation"},{"key":"2260_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.11.004","volume":"536","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo S, Hu D et al (2024) Enhanced Gasdermin-E-mediated pyroptosis in alzheimer\u2019s disease. Neuroscience 536:1\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.11.004","journal-title":"Neuroscience"},{"key":"2260_CR131","doi-asserted-by":"publisher","unstructured":"Demarco B, Grayczyk JP, Bjanes E et al (2020) Caspase-8\u2013dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality. Sci Adv 6. https:\/\/doi.org\/10.1126\/sciadv.abc3465","DOI":"10.1126\/sciadv.abc3465"},{"key":"2260_CR132","doi-asserted-by":"publisher","unstructured":"Kam T-I, Mao X, Park H et al (2018) Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science (80-) 362:. https:\/\/doi.org\/10.1126\/science.aat8407","DOI":"10.1126\/science.aat8407"},{"key":"2260_CR133","doi-asserted-by":"publisher","unstructured":"Puentes LN, Lengyel-Zhand Z, Lee JY et al (2021) Poly (ADP-ribose) interacts with phosphorylated \u03b1-Synuclein in post mortem PD samples. Front Aging Neurosci 13. https:\/\/doi.org\/10.3389\/fnagi.2021.704041","DOI":"10.3389\/fnagi.2021.704041"},{"key":"2260_CR134","doi-asserted-by":"crossref","unstructured":"Wu T, Yuan L, Sasaki Y et al (2025) SARM1 is an essential component of neuronal parthanatos","DOI":"10.1101\/2025.05.14.654090"},{"key":"2260_CR135","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","volume":"55","author":"E Lee","year":"2023","unstructured":"Lee E, Song C-H, Bae S-J et al (2023) Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis. Exp Mol Med 55:1632\u20131643. https:\/\/doi.org\/10.1038\/s12276-023-01069-y","journal-title":"Exp Mol Med"},{"key":"2260_CR136","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe T, Vanden et al (2019) The molecular machinery of regulated cell death. Cell Res 29:347\u2013364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5","journal-title":"Cell Res"},{"key":"2260_CR137","doi-asserted-by":"publisher","first-page":"101262","DOI":"10.1016\/j.gendis.2024.101262","volume":"11","author":"B Du","year":"2024","unstructured":"Du B, Deng Z, Chen K et al (2024) Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke. Genes Dis 11:101262. https:\/\/doi.org\/10.1016\/j.gendis.2024.101262","journal-title":"Genes Dis"},{"key":"2260_CR138","doi-asserted-by":"publisher","first-page":"9991001","DOI":"10.1155\/2021\/9991001","volume":"2021","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Liao J, Mei Z et al (2021) Insight into crosstalk between ferroptosis and necroptosis: novel therapeutics in ischemic stroke. Oxid Med Cell Longev 2021:9991001. https:\/\/doi.org\/10.1155\/2021\/9991001","journal-title":"Oxid Med Cell Longev"},{"key":"2260_CR139","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/STROKEAHA.116.015609","volume":"48","author":"M Zille","year":"2017","unstructured":"Zille M, Karuppagounder SS, Chen Y et al (2017) Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke 48:1033\u20131043. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015609","journal-title":"Stroke"},{"key":"2260_CR140","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Fang Z-M, Yi X et al (2023) The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis 14:205. https:\/\/doi.org\/10.1038\/s41419-023-05716-0","journal-title":"Cell Death Dis"},{"key":"2260_CR141","doi-asserted-by":"publisher","first-page":"112774","DOI":"10.1016\/j.intimp.2024.112774","volume":"139","author":"AA El-Gazar","year":"2024","unstructured":"El-Gazar AA, Soubh AA, Abdallah DM et al (2024) Elucidating PAR1 as a therapeutic target for delayed traumatic brain injury: unveiling the PPAR-\u03b3\/Nrf2\/HO-1\/GPX4 axis to suppress ferroptosis and alleviate NLRP3 inflammasome activation in rats. Int Immunopharmacol 139:112774. https:\/\/doi.org\/10.1016\/j.intimp.2024.112774","journal-title":"Int Immunopharmacol"},{"key":"2260_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.12.262","volume":"179","author":"G Chen","year":"2022","unstructured":"Chen G, Li C, Zhang L et al (2022) Hydroxysafflor yellow A and anhydrosafflor yellow B alleviate ferroptosis and parthanatos in PC12 cells injured by OGD\/R. Free Radic Biol Med 179:1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.12.262","journal-title":"Free Radic Biol Med"},{"key":"2260_CR143","doi-asserted-by":"publisher","unstructured":"Zheng D, Liu J, Piao H et al (2022) ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1039241","DOI":"10.3389\/fimmu.2022.1039241"},{"key":"2260_CR144","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.immuni.2024.02.011","volume":"57","author":"KE Lawlor","year":"2024","unstructured":"Lawlor KE, Murphy JM, Vince JE (2024) Gasdermin and MLKL necrotic cell death effectors: signaling and diseases. Immunity 57:429\u2013445. https:\/\/doi.org\/10.1016\/j.immuni.2024.02.011","journal-title":"Immunity"},{"key":"2260_CR145","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. Cell Mol Immunol 18:2114\u20132127. https:\/\/doi.org\/10.1038\/s41423-021-00740-6","journal-title":"Cell Mol Immunol"},{"key":"2260_CR146","doi-asserted-by":"publisher","unstructured":"Lei X, Chen Y, Lien E, Fitzgerald KA (2023) MLKL-Driven inflammasome activation and Caspase-8 mediate inflammatory cell death in influenza A virus infection. https:\/\/doi.org\/10.1128\/mbio.00110-23. MBio 14:","DOI":"10.1128\/mbio.00110-23"},{"key":"2260_CR147","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41467-023-36626-6","volume":"14","author":"KSG de S\u00e1","year":"2023","unstructured":"de S\u00e1 KSG, Amaral LA, Rodrigues TS et al (2023) Gasdermin-D activation promotes NLRP3 activation and host resistance to leishmania infection. Nat Commun 14:1049. https:\/\/doi.org\/10.1038\/s41467-023-36626-6","journal-title":"Nat Commun"},{"key":"2260_CR148","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.cell.2024.03.008","volume":"187","author":"L David","year":"2024","unstructured":"David L, Borges JP, Hollingsworth LR et al (2024) NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks. Cell 187:2224\u20132235e16. https:\/\/doi.org\/10.1016\/j.cell.2024.03.008","journal-title":"Cell"},{"key":"2260_CR149","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s13287-021-02532-1","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Guan Q, Shi H et al (2021) A novel RIP1\/RIP3 dual inhibitor promoted OPC survival and myelination in a rat neonatal white matter injury model with hOPC graft. Stem Cell Res Ther 12:462. https:\/\/doi.org\/10.1186\/s13287-021-02532-1","journal-title":"Stem Cell Res Ther"},{"key":"2260_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-019-0980-6","volume":"39","author":"EA Prokhorova","year":"2020","unstructured":"Prokhorova EA, Egorshina AY, Zhivotovsky B, Kopeina GS (2020) The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death. Oncogene 39:1\u201316. https:\/\/doi.org\/10.1038\/s41388-019-0980-6","journal-title":"Oncogene"},{"key":"2260_CR151","doi-asserted-by":"publisher","first-page":"101239","DOI":"10.1016\/j.redox.2019.101239","volume":"26","author":"N Robinson","year":"2019","unstructured":"Robinson N, Ganesan R, Heged\u0171s C et al (2019) Programmed necrotic cell death of macrophages: focus on pyroptosis, necroptosis, and parthanatos. Redox Biol 26:101239. https:\/\/doi.org\/10.1016\/j.redox.2019.101239","journal-title":"Redox Biol"},{"key":"2260_CR152","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3390\/cells9102286","volume":"9","author":"E Paldino","year":"2020","unstructured":"Paldino E, D\u2019Angelo V, Laurenti D et al (2020) Modulation of inflammasome and pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6\/2 mouse model of huntington\u2019s disease. Cells 9:2286. https:\/\/doi.org\/10.3390\/cells9102286","journal-title":"Cells"},{"key":"2260_CR153","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/0109298665333926240927074528","volume":"31","author":"H Zhong","year":"2024","unstructured":"Zhong H, Liu H, Fu Q (2024) Ferroptosis as a therapeutic target in neurodegenerative diseases: exploring the mechanisms and potential of treating alzheimer\u2019s disease and parkinson\u2019s disease. Protein Pept Lett 31:759\u2013772. https:\/\/doi.org\/10.2174\/0109298665333926240927074528","journal-title":"Protein Pept Lett"},{"key":"2260_CR154","doi-asserted-by":"publisher","unstructured":"Zhang L, Luo YL, Xiang Y et al (2024) Ferroptosis inhibitors: past, present and future. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/fphar.2024.1407335","DOI":"10.3389\/fphar.2024.1407335"},{"key":"2260_CR155","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4103\/1673-5374.274344","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Fan B-Y, Pang Y-L et al (2020) Neuroprotective effect of deferoxamine on erastininduced ferroptosis in primary cortical neurons. Neural Regen Res 15:1539. https:\/\/doi.org\/10.4103\/1673-5374.274344","journal-title":"Neural Regen Res"},{"key":"2260_CR156","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2018.01.019","volume":"117","author":"A Jelinek","year":"2018","unstructured":"Jelinek A, Heyder L, Daude M et al (2018) Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. Free Radic Biol Med 117:45\u201357. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.01.019","journal-title":"Free Radic Biol Med"},{"key":"2260_CR157","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4103\/1673-5374.293157","volume":"16","author":"B-Y Fan","year":"2021","unstructured":"Fan B-Y, Pang Y-L, Li W-X et al (2021) Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by Inhibition of glutathione peroxidase 4. Neural Regen Res 16:561. https:\/\/doi.org\/10.4103\/1673-5374.293157","journal-title":"Neural Regen Res"},{"key":"2260_CR158","doi-asserted-by":"publisher","unstructured":"Abdalkader M, Lampinen R, Kanninen KM et al (2018) Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci 12. https:\/\/doi.org\/10.3389\/fnins.2018.00466","DOI":"10.3389\/fnins.2018.00466"},{"key":"2260_CR159","doi-asserted-by":"publisher","unstructured":"Dong W, Gong F, Zhao Y et al (2023) Ferroptosis and mitochondrial dysfunction in acute central nervous system injury. Front Cell Neurosci 17. https:\/\/doi.org\/10.3389\/fncel.2023.1228968","DOI":"10.3389\/fncel.2023.1228968"},{"key":"2260_CR160","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41598-017-18935-1","volume":"8","author":"C Wu","year":"2018","unstructured":"Wu C, Zhao W, Yu J et al (2018) Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells. Sci Rep 8:574. https:\/\/doi.org\/10.1038\/s41598-017-18935-1","journal-title":"Sci Rep"},{"key":"2260_CR161","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/brainsci13101367","volume":"13","author":"H-Y Tian","year":"2023","unstructured":"Tian H-Y, Huang B-Y, Nie H-F et al (2023) The interplay between mitochondrial dysfunction and ferroptosis during Ischemia-Associated central nervous system diseases. Brain Sci 13:1367. https:\/\/doi.org\/10.3390\/brainsci13101367","journal-title":"Brain Sci"},{"key":"2260_CR162","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an Iron-Dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"2260_CR163","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J et al (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1","journal-title":"Signal Transduct Target Ther"},{"key":"2260_CR164","doi-asserted-by":"publisher","unstructured":"Ashraf A, So P-W (2020) Spotlight on ferroptosis: Iron-Dependent cell death in alzheimer\u2019s disease. Front Aging Neurosci 12. https:\/\/doi.org\/10.3389\/fnagi.2020.00196","DOI":"10.3389\/fnagi.2020.00196"},{"key":"2260_CR165","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.jmedchem.2c01621","volume":"66","author":"CR Gardner","year":"2023","unstructured":"Gardner CR, Davies KA, Zhang Y et al (2023) From (Tool)Bench to bedside: the potential of necroptosis inhibitors. J Med Chem 66:2361\u20132385. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01621","journal-title":"J Med Chem"},{"key":"2260_CR166","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20:19\u201333. https:\/\/doi.org\/10.1038\/s41583-018-0093-1","journal-title":"Nat Rev Neurosci"},{"key":"2260_CR167","doi-asserted-by":"publisher","first-page":"109112","DOI":"10.1016\/j.celrep.2021.109112","volume":"35","author":"M Zelic","year":"2021","unstructured":"Zelic M, Pontarelli F, Woodworth L et al (2021) RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. Cell Rep 35:109112. https:\/\/doi.org\/10.1016\/j.celrep.2021.109112","journal-title":"Cell Rep"},{"key":"2260_CR168","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12964-024-01796-3","volume":"22","author":"Q Gong","year":"2024","unstructured":"Gong Q, Ali T, Hu Y et al (2024) RIPK1 Inhibition mitigates neuroinflammation and rescues depressive-like behaviors in a mouse model of LPS-induced depression. Cell Commun Signal 22:427. https:\/\/doi.org\/10.1186\/s12964-024-01796-3","journal-title":"Cell Commun Signal"},{"key":"2260_CR169","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.4110\/in.2018.18.e41","volume":"18","author":"Y-S Yi","year":"2018","unstructured":"Yi Y-S (2018) Regulatory roles of the Caspase-11 Non-Canonical inflammasome in inflammatory diseases. Immune Netw 18:e41. https:\/\/doi.org\/10.4110\/in.2018.18.e41","journal-title":"Immune Netw"},{"key":"2260_CR170","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.apsb.2020.07.014","volume":"11","author":"J Ye","year":"2021","unstructured":"Ye J, Zeng B, Zhong M et al (2021) Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling. Acta Pharm Sin B 11:112\u2013126. https:\/\/doi.org\/10.1016\/j.apsb.2020.07.014","journal-title":"Acta Pharm Sin B"},{"key":"2260_CR171","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.3390\/ijms241210402","volume":"24","author":"Y-S Yi","year":"2023","unstructured":"Yi Y-S (2023) Regulatory roles of flavonoids in Caspase-11 Non-Canonical Inflammasome-Mediated inflammatory responses and diseases. Int J Mol Sci 24:10402. https:\/\/doi.org\/10.3390\/ijms241210402","journal-title":"Int J Mol Sci"},{"key":"2260_CR172","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R (2025) NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol 22:341\u2013355. https:\/\/doi.org\/10.1038\/s41423-025-01275-w","journal-title":"Cell Mol Immunol"},{"key":"2260_CR173","doi-asserted-by":"publisher","first-page":"922331","DOI":"10.3389\/fnins.2022.922331","volume":"16","author":"X Wu","year":"2022","unstructured":"Wu X, Wan T, Gao X et al (2022) Microglia pyroptosis: A candidate target for neurological diseases treatment. Front Neurosci 16:922331. https:\/\/doi.org\/10.3389\/fnins.2022.922331","journal-title":"Front Neurosci"},{"key":"2260_CR174","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mds.29748","volume":"39","author":"J Patel","year":"2024","unstructured":"Patel J, Dawson VL, Dawson TM (2024) Blocking the Self-Destruct program of dopamine neurons through macrophage migration inhibitory factor nuclease Inhibition. Mov Disord 39:644\u2013650. https:\/\/doi.org\/10.1002\/mds.29748","journal-title":"Mov Disord"},{"key":"2260_CR175","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s43556-024-00230-x","volume":"5","author":"S Zhao","year":"2024","unstructured":"Zhao S, Di Y, Fan H et al (2024) Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications. Mol Biomed 5:60. https:\/\/doi.org\/10.1186\/s43556-024-00230-x","journal-title":"Mol Biomed"},{"key":"2260_CR176","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1039\/D0NR06249A","volume":"13","author":"Y Mo","year":"2021","unstructured":"Mo Y, Duan L, Yang Y et al (2021) Nanoparticles improved Resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage. Nanoscale 13:3827\u20133840. https:\/\/doi.org\/10.1039\/D0NR06249A","journal-title":"Nanoscale"},{"key":"2260_CR177","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11051-024-05983-8","volume":"26","author":"A Alqudah","year":"2024","unstructured":"Alqudah A, Aljabali AA, Gammoh O, Tambuwala MM (2024) Advancements in neurotherapeutics: nanoparticles overcoming the blood\u2013brain barrier for precise CNS targeting. J Nanoparticle Res 26:123. https:\/\/doi.org\/10.1007\/s11051-024-05983-8","journal-title":"J Nanoparticle Res"},{"key":"2260_CR178","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","volume":"17","author":"F Chen","year":"2024","unstructured":"Chen F, Kang R, Tang D, Liu J (2024) Ferroptosis: principles and significance in health and disease. J Hematol Oncol 17:41. https:\/\/doi.org\/10.1186\/s13045-024-01564-3","journal-title":"J Hematol Oncol"},{"key":"2260_CR179","doi-asserted-by":"publisher","first-page":"102891","DOI":"10.1016\/j.sbi.2024.102891","volume":"88","author":"KA Davies","year":"2024","unstructured":"Davies KA, Czabotar PE, Murphy JM (2024) Death at a funeral: activation of the dead enzyme, MLKL, to kill cells by necroptosis. Curr Opin Struct Biol 88:102891. https:\/\/doi.org\/10.1016\/j.sbi.2024.102891","journal-title":"Curr Opin Struct Biol"},{"key":"2260_CR180","doi-asserted-by":"publisher","unstructured":"Bonnet MC, Sun L (2024) Editorial: necroptosis: from bench to bedside. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1441901","DOI":"10.3389\/fimmu.2024.1441901"},{"key":"2260_CR181","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41420-025-02579-6","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhao D, Wang T et al (2025) Pyroptosis, a double-edged sword during pathogen infection: a review. Cell Death Discov 11:289. https:\/\/doi.org\/10.1038\/s41420-025-02579-6","journal-title":"Cell Death Discov"},{"key":"2260_CR182","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","volume":"75","author":"Q Ma","year":"2023","unstructured":"Ma Q (2023) Pharmacological Inhibition of the NLRP3 inflammasome: Structure, molecular Activation, and Inhibitor-NLRP3 interaction. Pharmacol Rev 75:487\u2013520. https:\/\/doi.org\/10.1124\/pharmrev.122.000629","journal-title":"Pharmacol Rev"},{"key":"2260_CR183","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/acsptsci.4c00061","volume":"7","author":"JR Doedens","year":"2024","unstructured":"Doedens JR, Smolak P, Nguyen M et al (2024) Pharmacological analysis of NLRP3 inflammasome inhibitor sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in cellular and mouse models of inflammation provides a translational. ACS Pharmacol Transl Sci 7:1438\u20131456. https:\/\/doi.org\/10.1021\/acsptsci.4c00061","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2260_CR184","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/bph.15344","volume":"178","author":"Z Regdon","year":"2021","unstructured":"Regdon Z, Dem\u00e9ny MA, Kov\u00e1cs K et al (2021) High-content screening identifies inhibitors of oxidative stress\u2010induced parthanatos: cytoprotective and anti\u2010inflammatory effects of Ciclopirox. Br J Pharmacol 178:1095\u20131113. https:\/\/doi.org\/10.1111\/bph.15344","journal-title":"Br J Pharmacol"},{"key":"2260_CR185","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbpa.2017.05.007","volume":"39","author":"Y Li","year":"2017","unstructured":"Li Y, Qian L, Yuan J (2017) Small molecule probes for cellular death machines. Curr Opin Chem Biol 39:74\u201382. https:\/\/doi.org\/10.1016\/j.cbpa.2017.05.007","journal-title":"Curr Opin Chem Biol"},{"key":"2260_CR186","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11064-022-03782-y","volume":"48","author":"S Guo","year":"2023","unstructured":"Guo S, Lei Q, Guo H et al (2023) Edaravone attenuates A\u03b2 1-42-Induced inflammatory damage and ferroptosis in HT22 cells. Neurochem Res 48:570\u2013578. https:\/\/doi.org\/10.1007\/s11064-022-03782-y","journal-title":"Neurochem Res"},{"key":"2260_CR187","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1007\/s12035-022-03014-y","volume":"59","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhou W, Li J et al (2022) Senegenin rescues PC12 cells with oxidative damage through Inhibition of ferroptosis. Mol Neurobiol 59:6983\u20136992. https:\/\/doi.org\/10.1007\/s12035-022-03014-y","journal-title":"Mol Neurobiol"},{"key":"2260_CR188","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2021.07.081","volume":"572","author":"L Shao","year":"2021","unstructured":"Shao L, Dong C, Geng D et al (2021) Ginkgolide B protects against cognitive impairment in senescence-accelerated P8 mice by mitigating oxidative stress, inflammation and ferroptosis. Biochem Biophys Res Commun 572:7\u201314. https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.081","journal-title":"Biochem Biophys Res Commun"},{"key":"2260_CR189","doi-asserted-by":"publisher","first-page":"108002","DOI":"10.1016\/j.intimp.2021.108002","volume":"99","author":"Y Gao","year":"2021","unstructured":"Gao Y, Li J, Wu Q et al (2021) Tetrahydroxy Stilbene glycoside ameliorates alzheimer\u2019s disease in APP\/PS1 mice via glutathione peroxidase related ferroptosis. Int Immunopharmacol 99:108002. https:\/\/doi.org\/10.1016\/j.intimp.2021.108002","journal-title":"Int Immunopharmacol"},{"key":"2260_CR190","doi-asserted-by":"publisher","first-page":"104931","DOI":"10.1016\/j.neuint.2020.104931","volume":"144","author":"Y Liu","year":"2021","unstructured":"Liu Y, Chen Z, Li B et al (2021) Supplementation with \u03b3-glutamylcysteine (\u03b3-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves Spatial memory in a murine model of AD. Neurochem Int 144:104931. https:\/\/doi.org\/10.1016\/j.neuint.2020.104931","journal-title":"Neurochem Int"},{"key":"2260_CR191","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","volume":"14","author":"Y-H Zhang","year":"2018","unstructured":"Zhang Y-H, Wang D-W, Xu S-F et al (2018) \u03b1-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau Transgenic mice. Redox Biol 14:535\u2013548. https:\/\/doi.org\/10.1016\/j.redox.2017.11.001","journal-title":"Redox Biol"},{"key":"2260_CR192","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/acschemneuro.1c00516","volume":"13","author":"X-X Qu","year":"2022","unstructured":"Qu X-X, He J-H, Cui Z-Q et al (2022) PPAR-\u03b1 agonist GW7647 protects against oxidative stress and iron deposit via GPx4 in a Transgenic mouse model of alzheimer\u2019s diseases. ACS Chem Neurosci 13:207\u2013216. https:\/\/doi.org\/10.1021\/acschemneuro.1c00516","journal-title":"ACS Chem Neurosci"},{"key":"2260_CR193","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.redox.2022.102229","volume":"50","author":"J-J Tang","year":"2022","unstructured":"Tang J-J, Huang L-F, Deng J-L et al (2022) Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD alzheimer\u2019s disease mice model. Redox Biol 50:102229. https:\/\/doi.org\/10.1016\/j.redox.2022.102229","journal-title":"Redox Biol"},{"key":"2260_CR194","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/antiox11020295","volume":"11","author":"JH Yang","year":"2022","unstructured":"Yang JH, Nguyen CD, Lee G, Na C-S (2022) Insamgobonhwan protects neuronal cells from lipid ROS and improves deficient cognitive function. Antioxidants 11:295. https:\/\/doi.org\/10.3390\/antiox11020295","journal-title":"Antioxidants"},{"key":"2260_CR195","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.7150\/ijbs.69714","volume":"18","author":"C Wang","year":"2022","unstructured":"Wang C, Chen S, Guo H et al (2022) Forsythoside A mitigates Alzheimer\u2019s-like pathology by inhibiting Ferroptosis-mediated neuroinflammation via Nrf2\/GPX4 axis activation. Int J Biol Sci 18:2075\u20132090. https:\/\/doi.org\/10.7150\/ijbs.69714","journal-title":"Int J Biol Sci"},{"key":"2260_CR196","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13020-022-00634-3","volume":"17","author":"S Yang","year":"2022","unstructured":"Yang S, Xie Z, Pei T et al (2022) Salidroside attenuates neuronal ferroptosis by activating the Nrf2\/HO1 signaling pathway in A\u03b21-42-induced alzheimer\u2019s disease mice and glutamate-injured HT22 cells. Chin Med 17:82. https:\/\/doi.org\/10.1186\/s13020-022-00634-3","journal-title":"Chin Med"},{"key":"2260_CR197","doi-asserted-by":"publisher","first-page":"154762","DOI":"10.1016\/j.phymed.2023.154762","volume":"114","author":"S Yang","year":"2023","unstructured":"Yang S, Wang L, Zeng Y et al (2023) Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2\/GPX4 axis in SAMP8 mice. Phytomedicine 114:154762. https:\/\/doi.org\/10.1016\/j.phymed.2023.154762","journal-title":"Phytomedicine"},{"key":"2260_CR198","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10020-022-00442-3","volume":"28","author":"L Li","year":"2022","unstructured":"Li L, Li W-J, Zheng X-R et al (2022) Eriodictyol ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Mol Med 28:11. https:\/\/doi.org\/10.1186\/s10020-022-00442-3","journal-title":"Mol Med"},{"key":"2260_CR199","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","volume":"46","author":"B Avc\u0131","year":"2021","unstructured":"Avc\u0131 B, G\u00fcnayd\u0131n C, G\u00fcven\u00e7 T et al (2021) Idebenone ameliorates Rotenone-Induced parkinson\u2019s disease in rats through decreasing lipid peroxidation. Neurochem Res 46:513\u2013522. https:\/\/doi.org\/10.1007\/s11064-020-03186-w","journal-title":"Neurochem Res"},{"key":"2260_CR200","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","volume":"46","author":"X Zeng","year":"2021","unstructured":"Zeng X, An H, Yu F et al (2021) Benefits of iron chelators in the treatment of parkinson\u2019s disease. Neurochem Res 46:1239\u20131251. https:\/\/doi.org\/10.1007\/s11064-021-03262-9","journal-title":"Neurochem Res"},{"key":"2260_CR201","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.jchemneu.2022.102103","volume":"122","author":"L Wang","year":"2022","unstructured":"Wang L, An H, Yu F et al (2022) The neuroprotective effects of Paeoniflorin against MPP+-induced damage to dopaminergic neurons via the Akt\/Nrf2\/GPX4 pathway. J Chem Neuroanat 122:102103. https:\/\/doi.org\/10.1016\/j.jchemneu.2022.102103","journal-title":"J Chem Neuroanat"},{"key":"2260_CR202","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","volume":"17","author":"Y Tian","year":"2020","unstructured":"Tian Y, Lu J, Hao X et al (2020) FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of parkinson\u2019s disease. Neurotherapeutics 17:1796\u20131812. https:\/\/doi.org\/10.1007\/s13311-020-00929-z","journal-title":"Neurotherapeutics"},{"key":"2260_CR203","doi-asserted-by":"publisher","first-page":"b22","DOI":"10.1248\/bpb.b22-00529","volume":"46","author":"N Okada","year":"2023","unstructured":"Okada N, Nakamura S, Shimazawa M (2023) 3-Nitropropionic acid enhances ferroptotic cell death via NOX2-Mediated ROS generation in STHdhQ111 striatal cells carrying mutant Huntingtin. Biol Pharm Bull 46:b22\u201300529. https:\/\/doi.org\/10.1248\/bpb.b22-00529","journal-title":"Biol Pharm Bull"},{"key":"2260_CR204","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.nbd.2023.106210","volume":"184","author":"B Yang","year":"2023","unstructured":"Yang B, Pan J, Zhang X-N et al (2023) NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis. Neurobiol Dis 184:106210. https:\/\/doi.org\/10.1016\/j.nbd.2023.106210","journal-title":"Neurobiol Dis"},{"key":"2260_CR205","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/RNN-120304","volume":"31","author":"Z Qinli","year":"2013","unstructured":"Qinli Z, Meiqing L, Xia J et al (2013) Necrostatin-1 inhibits the degeneration of neural cells induced by aluminum exposure. Restor Neurol Neurosci 31:543\u2013555. https:\/\/doi.org\/10.3233\/RNN-120304","journal-title":"Restor Neurol Neurosci"},{"key":"2260_CR206","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acschemneuro.0c00516","volume":"11","author":"TMK Motawi","year":"2020","unstructured":"Motawi TMK, Abdel-Nasser ZM, Shahin NN (2020) Ameliorative effect of necrosulfonamide in a rat model of alzheimer\u2019s disease: targeting mixed lineage kinase Domain-like Protein-Mediated necroptosis. ACS Chem Neurosci 11:3386\u20133397. https:\/\/doi.org\/10.1021\/acschemneuro.0c00516","journal-title":"ACS Chem Neurosci"},{"key":"2260_CR207","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10787-023-01269-y","volume":"31","author":"R Abdelhady","year":"2023","unstructured":"Abdelhady R, Younis NS, Ali O et al (2023) Cognitive enhancing effects of pazopanib in D\u2013galactose\/ovariectomized alzheimer\u2019s rat model: insights into the role of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway. Inflammopharmacology 31:2719\u20132729. https:\/\/doi.org\/10.1007\/s10787-023-01269-y","journal-title":"Inflammopharmacology"},{"key":"2260_CR208","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1038\/s41598-023-35975-y","volume":"13","author":"Y-H Leem","year":"2023","unstructured":"Leem Y-H, Kim D-Y, Park J-E, Kim H-S (2023) Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and \u03b1-synuclein oligomerization in a subacute MPTP mouse model of parkinson\u2019s disease. Sci Rep 13:8783. https:\/\/doi.org\/10.1038\/s41598-023-35975-y","journal-title":"Sci Rep"},{"key":"2260_CR209","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/antiox9060524","volume":"9","author":"E Alegre-Cort\u00e9s","year":"2020","unstructured":"Alegre-Cort\u00e9s E, Muriel-Gonz\u00e1lez A, Canales-Cort\u00e9s S et al (2020) Toxicity of Necrostatin-1 in parkinson\u2019s disease models. Antioxidants 9:524. https:\/\/doi.org\/10.3390\/antiox9060524","journal-title":"Antioxidants"},{"key":"2260_CR210","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41374-019-0319-5","volume":"100","author":"Q-S Lin","year":"2020","unstructured":"Lin Q-S, Chen P, Wang W-X et al (2020) RIP1\/RIP3\/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease. Lab Investig 100:503\u2013511. https:\/\/doi.org\/10.1038\/s41374-019-0319-5","journal-title":"Lab Investig"},{"key":"2260_CR211","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ et al (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain Behav Immun"},{"key":"2260_CR212","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","volume":"116","author":"A Naeem","year":"2024","unstructured":"Naeem A, Prakash R, Kumari N et al (2024) MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of alzheimer\u2019s disease. Brain Behav Immun 116:70\u201384. https:\/\/doi.org\/10.1016\/j.bbi.2023.11.031","journal-title":"Brain Behav Immun"},{"key":"2260_CR213","doi-asserted-by":"publisher","first-page":"577543","DOI":"10.1016\/j.jneuroim.2021.577543","volume":"354","author":"S Huang","year":"2021","unstructured":"Huang S, Chen Z, Fan B et al (2021) A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of parkinson\u2019s disease. J Neuroimmunol 354:577543. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577543","journal-title":"J Neuroimmunol"},{"key":"2260_CR214","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","volume":"20","author":"A Grotemeyer","year":"2023","unstructured":"Grotemeyer A, Fischer JF, Koprich JB et al (2023) Inflammasome Inhibition protects dopaminergic neurons from \u03b1-synuclein pathology in a model of progressive parkinson\u2019s disease. J Neuroinflammation 20:79. https:\/\/doi.org\/10.1186\/s12974-023-02759-0","journal-title":"J Neuroinflammation"},{"key":"2260_CR215","doi-asserted-by":"publisher","unstructured":"Klein S (2020) Alpha-synuclein promotes dopaminergic neuron death in parkinson\u2019s disease through microglial and NLRP3 activation. USURJ Univ Sask Undergrad Res J 6. https:\/\/doi.org\/10.32396\/usurj.v6i2.425","DOI":"10.32396\/usurj.v6i2.425"},{"key":"2260_CR216","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y et al (2020) Microglial autophagy defect causes Parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy 16:2193\u20132205. https:\/\/doi.org\/10.1080\/15548627.2020.1719723","journal-title":"Autophagy"},{"key":"2260_CR217","doi-asserted-by":"publisher","unstructured":"Gordon R, Albornoz EA, Christie DC et al (2018) Inflammasome Inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"2260_CR218","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-023-02830-w","volume":"20","author":"J Amo-Aparicio","year":"2023","unstructured":"Amo-Aparicio J, Daly J, H\u00f8jen JF, Dinarello CA (2023) Pharmacologic Inhibition of NLRP3 reduces the levels of \u03b1-synuclein and protects dopaminergic neurons in a model of parkinson\u2019s disease. J Neuroinflammation 20:147. https:\/\/doi.org\/10.1186\/s12974-023-02830-w","journal-title":"J Neuroinflammation"},{"key":"2260_CR219","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/cells11081284","volume":"11","author":"A Maggiore","year":"2022","unstructured":"Maggiore A, Casale AM, Toscanelli W et al (2022) Neuroprotective effects of PARP inhibitors in drosophila models of alzheimer\u2019s disease. Cells 11:1284. https:\/\/doi.org\/10.3390\/cells11081284","journal-title":"Cells"},{"key":"2260_CR220","doi-asserted-by":"publisher","first-page":"e0134482","DOI":"10.1371\/journal.pone.0134482","volume":"10","author":"A Cardinale","year":"2015","unstructured":"Cardinale A, Paldino E, Giamp\u00e0 C et al (2015) PARP-1 Inhibition is neuroprotective in the R6\/2 mouse model of huntington\u2019s disease. PLoS ONE 10:e0134482. https:\/\/doi.org\/10.1371\/journal.pone.0134482","journal-title":"PLoS ONE"},{"key":"2260_CR221","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander G, Abdelhamid SG, Wahdan SA, Radwan SM (2025) Insights on the crosstalk among different cell death mechanisms. Cell Death Discov 11:56. https:\/\/doi.org\/10.1038\/s41420-025-02328-9","journal-title":"Cell Death Discov"},{"key":"2260_CR222","doi-asserted-by":"publisher","first-page":"17152","DOI":"10.1038\/s41598-022-22140-0","volume":"12","author":"G Dvoriantchikova","year":"2022","unstructured":"Dvoriantchikova G, Lypka KR, Adis EV, Ivanov D (2022) Multiple types of programmed necrosis such as necroptosis, pyroptosis, oxytosis\/ferroptosis, and parthanatos contribute simultaneously to retinal damage after ischemia\u2013reperfusion. Sci Rep 12:17152. https:\/\/doi.org\/10.1038\/s41598-022-22140-0","journal-title":"Sci Rep"},{"key":"2260_CR223","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuro.2022.11.003","volume":"94","author":"S Naderi","year":"2023","unstructured":"Naderi S, Khodagholi F, Pourbadie HG et al (2023) Role of amyloid beta (25\u2009\u2013\u200935) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in alzheimer\u2019s disease. Neurotoxicology 94:71\u201386. https:\/\/doi.org\/10.1016\/j.neuro.2022.11.003","journal-title":"Neurotoxicology"},{"key":"2260_CR224","doi-asserted-by":"publisher","first-page":"154132","DOI":"10.1016\/j.tox.2025.154132","volume":"515","author":"Y Cui","year":"2025","unstructured":"Cui Y, Zhang M, Xiao Y et al (2025) MLKL triggers NLRP3 activation in sodium arsenite-induced myocardial necroinflammation. Toxicology 515:154132. https:\/\/doi.org\/10.1016\/j.tox.2025.154132","journal-title":"Toxicology"},{"key":"2260_CR225","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1161\/ATVBAHA.124.321682","volume":"45","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li X, Xiao S et al (2025) PARylation of POLG mediated by PARP1 accelerates Ferroptosis-Induced vascular calcification via activating Adora2a\/Rap1 signaling. Arterioscler Thromb Vasc Biol 45:1175\u20131191. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321682","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2260_CR226","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Jia Y-C, Ding Y-X et al (2023) The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci 19:2756\u20132771. https:\/\/doi.org\/10.7150\/ijbs.83348","journal-title":"Int J Biol Sci"},{"key":"2260_CR227","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tcb.2024.01.010","volume":"34","author":"J Jacquemyn","year":"2024","unstructured":"Jacquemyn J, Ralhan I, Ioannou MS (2024) Driving factors of neuronal ferroptosis. Trends Cell Biol 34:535\u2013546. https:\/\/doi.org\/10.1016\/j.tcb.2024.01.010","journal-title":"Trends Cell Biol"},{"key":"2260_CR228","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-024-06807-2","volume":"15","author":"L Zeng","year":"2024","unstructured":"Zeng L, Yang K, Yu G et al (2024) Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases. Cell Death Dis 15:481. https:\/\/doi.org\/10.1038\/s41419-024-06807-2","journal-title":"Cell Death Dis"},{"key":"2260_CR229","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Sala D, Pajares MA (2023) Appraising the role of astrocytes as suppliers of neuronal glutathione precursors. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24098059","DOI":"10.3390\/ijms24098059"},{"key":"2260_CR230","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"2260_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01576-w","author":"W Wu","year":"2025","unstructured":"Wu W, Gong X, Qin Z, Wang Y (2025) Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-025-01576-w","journal-title":"Acta Pharmacol Sin"},{"key":"2260_CR232","doi-asserted-by":"publisher","unstructured":"Xiang H (2025) The interplay between \u03b1-synuclein aggregation and necroptosis in parkinson\u2019s disease: a Spatiotemporal perspective. Front Neurosci 19. https:\/\/doi.org\/10.3389\/fnins.2025.1567445","DOI":"10.3389\/fnins.2025.1567445"},{"key":"2260_CR233","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00011-023-01790-4","volume":"72","author":"Y-H Han","year":"2023","unstructured":"Han Y-H, Liu X-D, Jin M-H et al (2023) Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm Res 72:1839\u20131859. https:\/\/doi.org\/10.1007\/s00011-023-01790-4","journal-title":"Inflamm Res"},{"key":"2260_CR234","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-024-01799-6","volume":"10","author":"Y-C Yang","year":"2024","unstructured":"Yang Y-C, Jiang Q, Yang K-P et al (2024) Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy. Cell Death Discov 10:23. https:\/\/doi.org\/10.1038\/s41420-024-01799-6","journal-title":"Cell Death Discov"},{"key":"2260_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01109-4","author":"G Du","year":"2025","unstructured":"Du G, Wu H (2025) Gasdermin D pores Hitch a ride: extracellular vesicles spread pyroptosis. Cell Res. https:\/\/doi.org\/10.1038\/s41422-025-01109-4","journal-title":"Cell Res"},{"key":"2260_CR236","doi-asserted-by":"publisher","unstructured":"Battaglia AM, Sacco A, Giorgio E et al (2025) Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells. Front Cell Dev Biol 13. https:\/\/doi.org\/10.3389\/fcell.2025.1532097","DOI":"10.3389\/fcell.2025.1532097"},{"key":"2260_CR237","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cell.2024.11.018","volume":"188","author":"SS Wright","year":"2025","unstructured":"Wright SS, Kumari P, Fraile-\u00c1greda V et al (2025) Transplantation of gasdermin pores by extracellular vesicles propagates pyroptosis to bystander cells. Cell 188:280\u2013291e17. https:\/\/doi.org\/10.1016\/j.cell.2024.11.018","journal-title":"Cell"},{"key":"2260_CR238","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.crtox.2023.100134","volume":"5","author":"C Yarana","year":"2023","unstructured":"Yarana C, Maneechote C, Khuanjing T et al (2023) Potential roles of 4HNE-adducted protein in serum extracellular vesicles as an early indicator of oxidative response against doxorubicin-induced cardiomyopathy in rats. Curr Res Toxicol 5:100134. https:\/\/doi.org\/10.1016\/j.crtox.2023.100134","journal-title":"Curr Res Toxicol"},{"key":"2260_CR239","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/life15010070","volume":"15","author":"G Lerussi","year":"2025","unstructured":"Lerussi G, Villagrasa-Araya V, Molt\u00f3-Abad M et al (2025) Extracellular vesicles as tools for crossing the Blood\u2013Brain barrier to treat lysosomal storage diseases. Life 15:70. https:\/\/doi.org\/10.3390\/life15010070","journal-title":"Life"},{"key":"2260_CR240","doi-asserted-by":"publisher","unstructured":"Taha HB (2025) Alzheimer\u2019s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles. https:\/\/doi.org\/10.1038\/s44400-024-00002-y. npj Dement 1:3","DOI":"10.1038\/s44400-024-00002-y"},{"key":"2260_CR241","doi-asserted-by":"publisher","first-page":"1407335","DOI":"10.3389\/fphar.2024.1407335","volume":"15","author":"L Zhang","year":"2024","unstructured":"Zhang L, Luo YL, Xiang Y et al (2024) Ferroptosis inhibitors: past, present and future. Front Pharmacol 15:1407335. https:\/\/doi.org\/10.3389\/fphar.2024.1407335","journal-title":"Front Pharmacol"},{"key":"2260_CR242","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","volume":"8","author":"Y Du","year":"2022","unstructured":"Du Y, Guo Z (2022) Recent progress in ferroptosis: inducers and inhibitors. Cell Death Discov 8:501. https:\/\/doi.org\/10.1038\/s41420-022-01297-7","journal-title":"Cell Death Discov"},{"key":"2260_CR243","doi-asserted-by":"publisher","unstructured":"Zheng Y, Zhang X, Wang Z et al (2024) MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions. Arch Pharm (Weinheim) 357. https:\/\/doi.org\/10.1002\/ardp.202400459","DOI":"10.1002\/ardp.202400459"},{"key":"2260_CR244","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41419-025-07686-x","volume":"16","author":"B Villarejo-Zori","year":"2025","unstructured":"Villarejo-Zori B, Zapata-Mu\u00f1oz J, Sierra-Filardi E et al (2025) Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos. Cell Death Dis 16:402. https:\/\/doi.org\/10.1038\/s41419-025-07686-x","journal-title":"Cell Death Dis"}],"updated-by":[{"DOI":"10.1007\/s10495-026-02387-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000}}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02260-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T18:01:22Z","timestamp":1783274482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02260-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":244,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2260"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02260-y","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.cell.2022.04.020","asserted-by":"subject"}]},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised and Table 3 footnote and Figure 3 caption has been updated and misplaced text in article has been removed.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10495-026-02387-y","URL":"https:\/\/doi.org\/10.1007\/s10495-026-02387-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"72"}}